CN Patent
CN109485687A — 奥贝胆酸的晶型j及其制备方法
Assigned to CHENGDU HONGDA PHARMACEUTICAL Co Ltd · Expires 2019-03-19 · 7y expired
What this patent protects
本发明涉及奥贝胆酸的晶型J及其制备方法,以及无定型奥贝胆酸的制备。本发明获得的奥贝胆酸纯度高、水分含量小,在高温、高湿条件下增重均不明显,具有良好的稳定性,适合长期储存和工业化生产;且本发明的奥贝胆酸晶型J可转化为无定型奥贝胆酸,获得的无定型奥贝胆酸收率高,纯度好。
USPTO Abstract
本发明涉及奥贝胆酸的晶型J及其制备方法,以及无定型奥贝胆酸的制备。本发明获得的奥贝胆酸纯度高、水分含量小,在高温、高湿条件下增重均不明显,具有良好的稳定性,适合长期储存和工业化生产;且本发明的奥贝胆酸晶型J可转化为无定型奥贝胆酸,获得的无定型奥贝胆酸收率高,纯度好。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.